Curative cell therapies for type 1 diabetes: how close are we? 

Examine the development of cell therapies aimed at treating type 1 diabetes. Participants will gain insights into preclinical and clinical progress, challenges in translation, and strategies to enhance efficacy, safety, and durability of therapeutic interventions.

Key takeaways:

• Learn the latest advances in cell therapy for type 1 diabetes.
• Explore approaches to improve efficacy, safety, and durability.
• Understand translational challenges from preclinical models to patients.
• Apply insights into optimizing therapeutic design and delivery.
• Gain perspectives on timelines and strategies for achieving curative outcomes.